S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NASDAQ:SWAV

ShockWave Medical (SWAV) Stock Forecast, Price & News

$162.32
+16.35 (+11.20%)
(As of 05/13/2022 06:55 PM ET)
Add
Compare
Today's Range
$148.00
$162.47
50-Day Range
$115.91
$214.48
52-Week Range
$113.36
$249.73
Volume
736,600 shs
Average Volume
480,700 shs
Market Capitalization
$5.81 billion
P/E Ratio
210.81
Dividend Yield
N/A
Beta
1.5
30 days | 90 days | 365 days | Advanced Chart
Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

ShockWave Medical logo

About ShockWave Medical

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
657
Year Founded
N/A

Sales & Book Value

Annual Sales
$237.15 million
Book Value
$7.48 per share

Profitability

Net Income
$-9.14 million
Pretax Margin
9.85%

Debt

Price-To-Earnings

Miscellaneous

Free Float
30,316,000
Market Cap
$5.81 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
5/09/2022
Today
5/16/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.55 out of 5 stars

Medical Sector

108th out of 1,403 stocks

Surgical & Medical Instruments Industry

13th out of 137 stocks

Analyst Opinion: 3.4Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -













ShockWave Medical (NASDAQ:SWAV) Frequently Asked Questions

Is ShockWave Medical a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ShockWave Medical stock.
View analyst ratings for ShockWave Medical
or view top-rated stocks.

When is ShockWave Medical's next earnings date?

ShockWave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for ShockWave Medical
.

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings results on Monday, May, 9th. The company reported $0.39 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.20. The company had revenue of $93.70 million for the quarter, compared to the consensus estimate of $86.41 million. ShockWave Medical had a net margin of 9.70% and a trailing twelve-month return on equity of 12.36%. The company's quarterly revenue was up 193.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.68) earnings per share.
View ShockWave Medical's earnings history
.

What guidance has ShockWave Medical issued on next quarter's earnings?

ShockWave Medical updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $435.00 million-$455.00 million, compared to the consensus revenue estimate of $417.90 million.

What price target have analysts set for SWAV?

6 brokerages have issued twelve-month price objectives for ShockWave Medical's stock. Their forecasts range from $176.00 to $255.00. On average, they anticipate ShockWave Medical's share price to reach $207.86 in the next year. This suggests a possible upside of 28.1% from the stock's current price.
View analysts' price targets for ShockWave Medical
or view top-rated stocks among Wall Street analysts.

Who are ShockWave Medical's key executives?
ShockWave Medical's management team includes the following people:
  • Mr. Douglas E. Godshall M.B.A., Pres, CEO & Director (Age 57, Pay $972.39k)
  • Mr. Daniel Puckett MBA, CFO, Principal Financial Officer & Sec. (Age 58, Pay $568.34k)
  • Mr. Isaac Zacharias, Chief Commercial Officer (Age 47, Pay $571.37k) (LinkedIn Profile)
  • Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 55)
  • Mr. John M. Adams, Co-Founder and Technical Advisor (Age 75)
  • Mr. Mike Maszy, VP of Operations
  • Ms. Trinh Phung, Chief Accounting Officer, Principal Accounting Officer & VP of Fin. (Age 44)
  • Ms. Debbie Kaster, VP of Investor Relations
  • Mr. Hajime Tada J.D., Gen. Counsel & Sec.
  • Mr. Rob Williamson Jr., VP of Sales
What is Doug Godshall's approval rating as ShockWave Medical's CEO?

8 employees have rated ShockWave Medical CEO Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among ShockWave Medical's employees.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Square (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are ShockWave Medical's major shareholders?

ShockWave Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.25%), BlackRock Inc. (7.57%), JPMorgan Chase & Co. (3.28%), Lord Abbett & CO. LLC (1.71%), Baillie Gifford & Co. (1.67%) and Jennison Associates LLC (1.21%). Company insiders that own ShockWave Medical stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Sofinnova Capital Vii Fcpr and Trinh Phung.
View institutional ownership trends for ShockWave Medical
.

Which major investors are selling ShockWave Medical stock?

SWAV stock was sold by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Nantahala Capital Management LLC, Renaissance Technologies LLC, JPMorgan Chase & Co., Bellevue Group AG, First Trust Advisors LP, Ziegler Capital Management LLC, and Northern Trust Corp. Company insiders that have sold ShockWave Medical company stock in the last year include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, and Trinh Phung.
View insider buying and selling activity for ShockWave Medical
or view top insider-selling stocks.

Which major investors are buying ShockWave Medical stock?

SWAV stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Eagle Asset Management Inc., Frontier Capital Management Co. LLC, Vanguard Group Inc., Lisanti Capital Growth LLC, Lord Abbett & CO. LLC, Victory Capital Management Inc., and PEAK6 Investments LLC.
View insider buying and selling activity for ShockWave Medical
or or view top insider-buying stocks.

How do I buy shares of ShockWave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $162.32.

How much money does ShockWave Medical make?

ShockWave Medical has a market capitalization of $5.81 billion and generates $237.15 million in revenue each year. The company earns $-9.14 million in net income (profit) each year or $0.77 on an earnings per share basis.

How many employees does ShockWave Medical have?

ShockWave Medical employs 657 workers across the globe.

What is ShockWave Medical's official website?

The official website for ShockWave Medical is www.shockwavemedical.com.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at (510) 279-4262 or via email at [email protected].

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.